Juan M Hincapie-Castillo

Juan M Hincapie-Castillo, Pharm.D., M.S., Ph.D.

Assistant Professor

Department: Pharmaceutical Outcomes & Policy
Business Phone: (352) 273-5526
Business Email: j.hincapie@ufl.edu

About Juan M Hincapie-Castillo

Juan M. Hincapie-Castillo, Pharm.D, M.S., Ph.D., joined the Department of Pharmaceutical Outcomes and Policy as an assistant professor in 2019. He is a graduate from the University of Florida College of Pharmacy where he received the degrees of Doctor of Pharmacy (2013), Master of Science in Pharmaceutical Sciences (2017), and Ph.D. with a concentration in pharmacoepidemiology (2019). During his doctoral training, Dr. Hincapie-Castillo was appointed as a graduate fellow for the American Association of Hispanics in Higher Education, and he was the recipient of the University of Florida Graduate Student Teaching Award in 2016. He is the recipient of the 2020 New Investigator Award from the American Association of Colleges of Pharmacy and the 2020 Emerging Leader Award from the International Society for Pharmacoepidemiology. His research interests include the study of drug utilization and safety in the area of pain management, the evaluation of the effects of State and Federal laws on patient outcomes (legal epidemiology), and the assessment of patient safety and quality for inpatient pain management.

Accomplishments

New Investigator Award
2020 · American Association of Colleges of Pharmacy
Keynote Speaker – Doctoral & Master’s Commencement Summer 2020
2020 · University of Florida College of Pharmacy
Faculty Role Model Award
2020 · Comprehensive Cancer Research Training Opportunities for Outstanding Leaders (ReTOOL) Program
Emerging Leader Award
2020 · International Society for Pharmacoepidemiology
Best Reviewer Recognition in 2018
2019 · Pharmacoepidemiology and Drug Safety (Journal)

Research Profile

Drug utilization and safety in pain management, evaluation of the effects of State and Federal laws on patient outcomes (legal epidemiology), and assessment of patient safety and quality for inpatient pain management.

Open Researcher and Contributor ID (ORCID)

0000-0002-6945-2713

Areas of Interest
  • Legal Epidemiology
  • Pain Management
  • Pharmacoepidemiology
  • health services research

Publications

2020 The journal of pain : official journal of the American Pain Society
2019 American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
2017 Journal of the American Pharmacists Association : JAPhA
2017 American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Grants

Jan 2020 ACTIVE
Leveraging social media data for evaluation of drug use trends after opioid policies
AMER ASSO OF COL OF PHARMACY · Principal Investigator
Sep 2018 ACTIVE
University of Florida Resource Center for Minority Aging Research
NATL INST OF HLTH NIA · Project Manager

Education

Ph.D.
2019 · University of Florida
M.S.
2017 · University of Florida
Pharm.D.
2013 · University of Florida

Contact Details

Phones:
Business:
(352) 273-5526
Emails:
Business:
j.hincapie@ufl.edu

Recent news

Dr. Juan Hincapie-Castillo appointed as FDA committee consultant

Dr. Hincapie-Castillo has been appointed as a consultant to the FDA’s Drug Safety and Risk Management Advisory Committee.

Dr. Juan Hincapie-Castillo receives the 2020 Emerging Leader Award from the International Society for Pharmacoepidemiology

The Emerging Leader Award recognizes ISPE members that have shown early in their careers the potential for leadership and have already made significant contributions to the society.

Dr. Juan Hincapie-Castillo receives AACP New Investigator Award to evaluate opioid use trends via social media

Juan Hincapie-Castillo, Pharm.D., Ph.D., an assistant professor in the UF College of Pharmacy’s department of pharmaceutical outcomes and policy, has received a $10,000 grant from the American Association of Colleges…

New Florida law leads to decline in opioid use, according to UF study

UF researchers found the number of new opioid users per month dropped 16 percent immediately after Florida House Bill 21 was implemented.